159 related articles for article (PubMed ID: 12163380)
1. Pseudomyxoma peritonei is a disease of MUC2-expressing goblet cells.
O'Connell JT; Tomlinson JS; Roberts AA; McGonigle KF; Barsky SH
Am J Pathol; 2002 Aug; 161(2):551-64. PubMed ID: 12163380
[TBL] [Abstract][Full Text] [Related]
2. Pseudomyxoma peritonei: is disease progression related to microbial agents? A study of bacteria, MUC2 AND MUC5AC expression in disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis.
Semino-Mora C; Liu H; McAvoy T; Nieroda C; Studeman K; Sardi A; Dubois A
Ann Surg Oncol; 2008 May; 15(5):1414-23. PubMed ID: 18299935
[TBL] [Abstract][Full Text] [Related]
3. Secreted mucins in pseudomyxoma peritonei: pathophysiological significance and potential therapeutic prospects.
Amini A; Masoumi-Moghaddam S; Ehteda A; Morris DL
Orphanet J Rare Dis; 2014 May; 9():71. PubMed ID: 24886459
[TBL] [Abstract][Full Text] [Related]
4. High-Grade Appendiceal Mucinous Neoplasm: Clinicopathologic Findings in 35 Cases.
Gonzalez RS; Carr NJ; Liao H; Pai RK; Agostini-Vulaj D; Misdraji J
Arch Pathol Lab Med; 2022 Dec; 146(12):1471-1478. PubMed ID: 35472721
[TBL] [Abstract][Full Text] [Related]
5. Ovarian Causes of Pseudomyxoma Peritonei (PMP)-A Literature Review.
Ionescu S; Marincas M; Madge OL; Dicu-Andreescu IG; Chitoran E; Rotaru V; Cirimbei C; Gherghe M; Ene A; Rosca R; Radu M; Simion L
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672528
[TBL] [Abstract][Full Text] [Related]
6. Autophagy is required during high MUC2 mucin biosynthesis in colonic goblet cells to contend metabolic stress.
Tiwari S; Begum S; Moreau F; Gorman H; Chadee K
Am J Physiol Gastrointest Liver Physiol; 2021 Nov; 321(5):G489-G499. PubMed ID: 34494458
[TBL] [Abstract][Full Text] [Related]
7. Culture and Imaging of Ex Vivo Organotypic Pseudomyxoma Peritonei Tumor Slices from Resected Human Tumor Specimens.
Weitz J; Montecillo Gulay KC; Hurtado de Mendoza T; Tiriac H; Baumgartner J; Kelly K; Veerapong J; Lowy AM
J Vis Exp; 2022 Dec; (190):. PubMed ID: 36571414
[TBL] [Abstract][Full Text] [Related]
8. DOCK4 stimulates MUC2 production through its effect on goblet cell differentiation.
Qin T; Yang J; Huang D; Zhang Z; Huang Y; Chen H; Xu G
J Cell Physiol; 2021 Sep; 236(9):6507-6519. PubMed ID: 33559155
[TBL] [Abstract][Full Text] [Related]
9. Comparative transcriptomic analyses reveal activation of the epithelial-mesenchymal transition program in non-metastasizing low grade pseudomyxoma peritonei.
Pretzsch E; Neumann J; Nieß H; Pretzsch CM; Hofmann FO; Kirchner T; Klauschen F; Werner J; Angele M; Kumbrink J
Pathol Res Pract; 2024 Feb; 254():155129. PubMed ID: 38232629
[TBL] [Abstract][Full Text] [Related]
10. Exogenous NAD
Ma S; Yeom J; Lim YH
Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32283838
[TBL] [Abstract][Full Text] [Related]
11. Mucinous ascites: Pseudomyxoma peritonei.
Nepal S; Schwertner A; Cunningham JM
Cleve Clin J Med; 2022 Sep; 89(9):491-493. PubMed ID: 37907443
[No Abstract] [Full Text] [Related]
12. Breaking the Mucin Barrier: A New Affinity Chromatography-Mass Spectrometry Approach to Unveil Potential Cell Markers and Pathways Altered in Pseudomyxoma Peritonei.
Romero-Ruiz A; Granados-Rodríguez M; Bura FI; Valenzuela-Molina F; Rufián-Andújar B; Martínez-López A; Rodríguez-Ortiz L; Ortega-Salas R; Torres-Martínez M; Moreno-Serrano A; Castaño J; Michán C; Alhama J; Vázquez-Borrego MC; Arjona-Sánchez Á
Biol Proced Online; 2024 May; 26(1):13. PubMed ID: 38750435
[TBL] [Abstract][Full Text] [Related]
13. Intra-tumoural bromelain and N-acetylcysteine for recurrent and unresectable pseudomyxoma peritonei: phase I/II trial.
Rodríguez-Ortiz L; Vázquez-Borrego MC; Bura FI; Granados-Rodríguez M; Valenzuela-Molina F; Rufián-Andújar B; Martínez-López A; Ortega-Salas R; Espejo-Herrero JJ; Romero-Ruiz A; Arjona-Sánchez Á
Br J Surg; 2024 Mar; 111(3):. PubMed ID: 38477594
[No Abstract] [Full Text] [Related]
14. A Rare Case of Psoas Abscess Secondary to Mucinous Adenocarcinoma of the Appendix: A Case Report.
Prabhu RM; Koshire SR; Khandelwal RCS
J Orthop Case Rep; 2021 Aug; 11(8):1-5. PubMed ID: 35004364
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Treatment of Unresectable Pseudomyxoma Peritonei with Multiple Treatments of Intratumoural Bromelain and Acetylcysteine (BromAc
Yang J; Glenn D; Lodh S; Valle S; Morris DL
Case Rep Oncol; 2023; 16(1):1551-1556. PubMed ID: 38074518
[TBL] [Abstract][Full Text] [Related]
16. Germline and somatic genetic alterations in two first-degree relatives with appendiceal low-grade mucinous carcinoma peritonei.
King MC; Munoz-Zuluaga C; Ledakis P; Studeman K; Sittig M; Gushchin V; Sardi A
Clin Case Rep; 2020 Dec; 8(12):3168-3177. PubMed ID: 33363901
[TBL] [Abstract][Full Text] [Related]
17. Rare primary peritoneal mucinous adenocarcinoma in a 69-year-old man.
Satoh F; Tsutusmi Y
Clin Case Rep; 2021 Sep; 9(9):e04820. PubMed ID: 34532054
[TBL] [Abstract][Full Text] [Related]
18. Bromelain and acetylcysteine (BromAc
Wen HK; Valle SJ; Morris DL
Am J Cancer Res; 2023; 13(4):1522-1532. PubMed ID: 37168359
[TBL] [Abstract][Full Text] [Related]
19. Jelly-like Pleural Effusions: An Uncommon Manifestation of Pseudomyxoma Peritonei.
Ma Y; Qiao Z; Chen H
Arch Bronconeumol (Engl Ed); 2021 Jan; ():. PubMed ID: 33618915
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
